Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Urology Reports
Metadata
Title
Rofecoxib versus placebo in prostatitis
Author
Robert F. Donnell, MD
Publication date
01-07-2003
Publisher
Current Medicine Group
Published in
Current Urology Reports / Issue 4/2003
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-003-0089-9

Other articles of this Issue 4/2003

Current Urology Reports 4/2003 Go to the issue

Abstract

Literature alert

OriginalPaper

Prostatitis versus pelvic pain syndrome: Immunologic studies

OriginalPaper

The role of urodynamics in the diagnosis and treatment of benign prostatic hyperplasia

Invited Commentary

Prostatitis: Diagnosis and classification

OriginalPaper

The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia

OriginalPaper

Advanced therapy for prostatitis: Minimally invasive and invasive therapies